BackVaxart Overview

Vaxart Current Cash

Track Vaxart's current cash ($51M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$50.93M
↑ 153.24% YoYΔ $30.82M vs prior year quarter

Peer trimmed avg / median

Loading

Vaxart Current Cash History

Loading

Vaxart vs. peers: Current Cash Comparison

Loading

Vaxart Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Vaxart (VXRT) FAQ

Vaxart (VXRT) currently reports a current cash of $51M as of June 2026. That compares with $20M in the prior-year period — up 153.2% year over year. Use the charts on this page to explore Vaxart's current cash history and peer comparisons.

Vaxart's current cash increased from $20M to $51M — a 153.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vaxart reported $51M in current cash as of June 2026. That compares with $20M in the prior-year period — up 153.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $51M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vaxart, and consider following VXRT for alerts when major investors trade the stock.

Vaxart is classified in the Healthcare sector. On current cash, it currently shows $51M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VXRT with unrelated industries.